John Haanen

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


4 publications

Sous presse
 
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma.
Pal S.K., Tran B., Haanen JBAG, Hurwitz M.E., Sacher A., Tannir N.M., Budde L.E., Harrison S.J., Klobuch S., Patel S.S. et al. Cancer discovery. Peer-reviewed.
[DOI][Pmid][serval:BIB_380D2196CD9C]
2024
 
Melanoma neoantigen vaccines: Are we getting more personal now?
Latifyan S., Haanen J.B., 2024/04/12. Med, 5 (4) pp. 288-290. Peer-reviewed.
[DOI][Pmid][serval:BIB_362339C5E2F1]
 
Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access Protocol.
Verkerk K., Geurts B.S., Zeverijn L.J., van der Noort V., Verheul HMW, Haanen JBAG, van der Veldt AAM, Eskens FALM, Aarts MJB, van Herpen CML et al., 2024/04. The Lancet regional health. Europe, 39 p. 100875. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FB1F09F33DB5]
 
Tumor-Infiltrating Lymphocyte and Other Cell Therapies for Metastatic Melanoma.
Los C., Klobuch S., Haanen JBAG, 2024. Cancer journal, 30 (2) pp. 113-119. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2ECDF6921A25]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University